Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party, Online, from 20 January 2026, 09:30 (CET) to 20 January 2026, 13:00 (CET)

Submitted by Anonymous (not verified) on 3 March 2026 - 15:16

Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party, Online, from 20 January 2026, 09:30 (CET) to 20 January 2026, 13:00 (CET)

Human medicines European public assessment report (EPAR): Entyvio, vedolizumab, Date of authorisation: 22/05/2014, Revision: 32, Status: Authorised

Submitted by Anonymous (not verified) on 3 March 2026 - 15:00

Human medicines European public assessment report (EPAR): Entyvio, vedolizumab, Date of authorisation: 22/05/2014, Revision: 32, Status: Authorised

Human medicines European public assessment report (EPAR): Zeposia, ozanimod, Date of authorisation: 20/05/2020, Revision: 11, Status: Authorised

Submitted by Anonymous (not verified) on 3 March 2026 - 14:50

Human medicines European public assessment report (EPAR): Zeposia, ozanimod, Date of authorisation: 20/05/2020, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Vyloy, zolbetuximab, Date of authorisation: 19/09/2024, Revision: 4, Status: Authorised

Submitted by Anonymous (not verified) on 3 March 2026 - 14:25

Human medicines European public assessment report (EPAR): Vyloy, zolbetuximab, Date of authorisation: 19/09/2024, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR): Aqneursa, L-acetylleucine, Date of authorisation: 19/01/2026, Revision: 1, Status: Authorised

Submitted by Anonymous (not verified) on 3 March 2026 - 11:45

Human medicines European public assessment report (EPAR): Aqneursa, L-acetylleucine, Date of authorisation: 19/01/2026, Revision: 1, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness